Vera Therapeutics (VERA) Retained Earnings (2020 - 2026)
Vera Therapeutics (VERA) posted Retained Earnings of -$156000.0 for Q1 2026, down 119.85% on a QoQ basis from $786000.0 in Q4 2025, and up 99.97% year-over-year from -$78011.9 in Q1 2025.
Vera Therapeutics (VERA) Retained Earnings (2020 - 2026) Analysis & Trends
Vera Therapeutics' Retained Earnings history runs 7 years deep, the most recent figure standing at -$156000.0 for Q1 2026.
- Quarterly Retained Earnings rose 99.97% year-over-year to -$156000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$156000.0 (up 99.97% YoY) and the FY2025 annual result came in at $786000.0, up 100.17% from the prior year.
- Retained Earnings was -$156000.0 for Q1 2026 at Vera Therapeutics, down from $786000.0 in the prior quarter.
- Across five years, Retained Earnings topped out at $786000.0 in Q4 2025 and bottomed at -$669.8 million in Q3 2025.
- A 5-year average of -$154.2 million and a median of -$279000.0 in 2022 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2024 — Retained Earnings slumped 557000.0% — and 2025, when it jumped 217.11%.
- Vera Therapeutics' Retained Earnings stood at -$224000.0 in 2022, then surged by 212.05% to $251000.0 in 2023, then tumbled by 183864.94% to -$461.2 million in 2024, then surged by 100.17% to $786000.0 in 2025, then tumbled by 119.85% to -$156000.0 in 2026.
- Business Quant data shows VERA's Retained Earnings at -$156000.0 in Q1 2026, $786000.0 in Q4 2025, and -$669.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Vera Therapeutics | 2.60 Bn | 2.60 Bn | - | -156,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -156,000.00 |
| Dec 31, 2025 | 786,000.00 |
| Sep 30, 2025 | -669.80 Mn |
| Jun 30, 2025 | 527,000.00 |
| Mar 31, 2025 | -512.94 Mn |
| Dec 31, 2024 | -461.25 Mn |
| Sep 30, 2024 | -417.83 Mn |
| Jun 30, 2024 | -450,000.00 |
| Mar 31, 2024 | -173,000.00 |
| Dec 31, 2023 | 251,000.00 |
| Sep 30, 2023 | -75,000.00 |
| Jun 30, 2023 | -263.30 Mn |
| Mar 31, 2023 | -4,000.00 |
| Dec 31, 2022 | -224,000.00 |
| Sep 30, 2022 | -279,000.00 |
| Jun 30, 2022 | -155.99 Mn |
| Mar 31, 2022 | -141.10 Mn |
| Dec 31, 2021 | -124.06 Mn |
| Sep 30, 2021 | -107.21 Mn |
| Jun 30, 2021 | -99.60 Mn |